Other headlines:Cancer center CEO touts TomoTherapyHansen Medical president plans to leave
Varian Medical's RapidArc Therapy is up and running at Chang Gung Memorial Hospital in Taiwan, the first such facility in the island nation to offer the technology. Its first beneficiary, a 50-year-old male patient with head and neck cancer, was treated in two and a half minutes using two arcs, or rotations, of the machine. By comparison, conventional intensity-modulated radiotherapy treatments would have taken up to 10 minutes.
The chief executive at the West Michigan Cancer Center in Kalamazoo last week handed TomoTherapy some ammunition for its fight against the global economic meltdown. In a talk delivered at the Association of Cancer Executives annual meeting in Sarasota, FL, Terry McKay lauded TomoTherapy's integrated radiotherapy/imaging system as having "the greatest potential for enhancing cancer treatment moving forward." McKay described how the machine, in the months since its purchase, has allowed the treatment of complex cases at the Michigan center. "Our referring physicians are beginning to understand this," she said. "We are attracting more patients because of TomoTherapy."
Gary C. Restani will step down as president and COO of Hansen Medical March 1, and he will not seek reelection to its board of directors, according to a corporate filing with the Securities and Exchange Commission. A separation agreement signed Feb. 19 calls for the company to pay Restani his base salary and health benefits for 12 months beginning March 1 as well as provide him with 125,000 fully vested stock units. In return, Restani will immediately cancel all of his options to purchase shares of the company's common stock. Severance benefits are contingent on a general release by Restani of any claims against the company.
Earlier in the month, the company released fourth-quarter and year-end results, showing a 74% increase in revenue for the three months ended Dec. 31, 2008, to $7.3 million compared with the year-earlier period. The maker of surgical robots recorded a net loss for the three months of $14.9 million versus a net loss of $23.9 million in the year-earlier period. In fiscal 2008, total revenues nearly tripled to $30.2 million from $10.1 million. Net loss was $53.4 million compared with a loss of $50.4 million in the previous year.
Emerging AI Algorithm Shows Promise for Abbreviated Breast MRI in Multicenter Study
April 25th 2025An artificial intelligence algorithm for dynamic contrast-enhanced breast MRI offered a 93.9 percent AUC for breast cancer detection, and a 92.3 percent sensitivity in BI-RADS 3 cases, according to new research presented at the Society for Breast Imaging (SBI) conference.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.